Page last updated: 2024-10-31

mianserin and Capgras Syndrome

mianserin has been researched along with Capgras Syndrome in 2 studies

Mianserin: A tetracyclic compound with antidepressant effects. It may cause drowsiness and hematological problems. Its mechanism of therapeutic action is not well understood, although it apparently blocks alpha-adrenergic, histamine H1, and some types of serotonin receptors.
mianserin : A dibenzoazepine (specifically 1,2,3,4,10,14b-hexahydrodibenzo[c,f]pyrazino[1,2-a]azepine) methyl-substituted on N-2. Closely related to (and now mostly superseded by) the tetracyclic antidepressant mirtazapinean, it is an atypical antidepressant used in the treatment of depression throughout Europe and elsewhere.

Capgras Syndrome: A psychotic disorder characterized by the patient's belief that acquaintances or closely related persons have been replaced by doubles or imposters.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Spiegel, DR1
Laroia, R1
Samuels, D1
Khouzam, HR1

Other Studies

2 other studies available for mianserin and Capgras Syndrome

ArticleYear
A possible case of Capgras syndrome after a right anterior cerebral artery cerebrovascular accident treated successfully with mirtazapine.
    The Journal of neuropsychiatry and clinical neurosciences, 2008,Fall, Volume: 20, Issue:4

    Topics: Adrenergic alpha-Antagonists; Antipsychotic Agents; Capgras Syndrome; Electroencephalography; Female

2008
Capgras syndrome responding to the antidepressant mirtazapine.
    Comprehensive therapy, 2002,Fall, Volume: 28, Issue:3

    Topics: Aged; Antidepressive Agents; Capgras Syndrome; Humans; Male; Mianserin; Mirtazapine

2002